Journal of Parkinson’s Disease
- ISSN
- 1877-7171
- Volume
- 1; 4 issues
- Status
- Last issue (2:1) published on 29 March 2012
- Next issue
- 2:2 scheduled for June 2012
- Website
- www.journalofparkinsonsdisease.com
- Subject
- Neurosciences
The Journal of Parkinson’s Disease is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that will expedite our fundamental understanding and improve treatment of Parkinson’s disease. The journal is international and multidisciplinary and aims to promote progress in the epidemiology, etiology, genetics, molecular correlates, pathogenesis, pharmacology, psychology, diagnosis and treatment of Parkinson’s disease. It will publish research reports, reviews, short communications, and letters-to-the-editor and offers very rapid publication and an affordable open access option.
Click here to see: Editor-in-Chief Patrik Brundin introduces the Journal of Parkinson’s Disease.
Editors-in-Chief Patrik Brundin, MD, PhD J. William Langston, MD Associate Editor for Reviews M. Angela Cenci Associate Editors Roger Barker Mark Cookson Dennis Dickson Robert Edwards Howard Federoff Thomas Gasser Glenda Halliday Jan Petter Larsen Andres Lozano Tamas Revesz Nick Wood | Editorial Board Dag Aarsland, Norway |
SciVerse Scopus
17 June 2012 - 21 June 2012
Dublin
Ireland
The 16th Congress of the European Federation of Neurological Societies
08 September 2012 - 11 September 2012
Stockholm
Sweden
100 Years of Lewy Bodies
15 September 2012 - 15 September 2012
Munich
Germany
XX WFN World Congress on Parkinson’s Disease and Related Disorders
08 December 2013 - 11 December 2013
Geneva
Switzerland
19th Century Therapy for Parkinson’s Disease May Help Patients Today
23 Apr 2012 - In the 19th century, the celebrated neurologist, Jean-Martin Charcot, developed a “vibration chair” to relieve symptoms of Parkinson’s disease. He reported improvements in his patients, but he died shortly thereafter and a more complete evaluation of the therapy was never conducted. Now a group of scientists at Rush University Medical Center have replicated his work, and they report that wh...
New Findings and Imaging Techniques May Aid Diagnosis of Concomitant Alzheimer’s in Patients with Parkinson’s Disease Dementia
17 Apr 2012 - Dementia is a frequent complication of Parkinson’s disease (PD), but it is clinically impossible to distinguish PD dementia (PDD), which develops from the progression of the Lewy body pathology that underlies PD, from PD with coexistent Alzheimer’s disease (PDAD). Both have similar characteristics. A team of scientists has found that PDAD patients have much denser accumulations of amyloid plaq...
Journal of Parkinson's Disease Brochure 2012
27 Feb 2012 - Download the Journal of Parkinson's Disease Brochure 2012 here. ...
Scientists Report First Step in Strategy for Cell Replacement Therapy in Parkinson’s Disease
25 Jan 2012 - Induced pluripotent stem cells (iPSC) are a promising avenue for cell replacement therapy in neurologic diseases. For example, mouse and human iPSCs have been used to generate dopaminergic (DA) neurons that improve symptoms in rat Parkinson’s disease models. Reporting in the current issue of the Journal of Parkinson’s Disease, a group of scientists from Japan evaluated the growth, differentiat...
New Research Reveals How α-Synuclein Interacts with Cell Membranes in Parkinson’s Disease
19 Jan 2012 - The accumulation of α-synuclein, a small, negatively charged protein, in neural cells, is one of the hallmarks of Parkinson’s disease. It has been suggested that oligomeric α-synuclein causes membranes to become permeable, or to form channels on the outer cell membrane. Now, a group of scientists from Sweden has found a way to reliably replicate α-synuclein aggregation on cell membranes to ...
New Study Supports View that Lewy Bodies Are Not the Primary Cause of Cell Death in Parkinson’s Disease
10 Jan 2012 - The pathology of Parkinson’s disease is characterized by a loss of dopamine-producing neurons in the pars compacta of the substantia nigra (SN), an area of the brain associated with motor control, along with the development of α-synuclein (αS) protein in the form of Lewy bodies (LB) in the neurons that survive. The spread of LB pathology is thought to progress along with the clinical course o...
Genetic Factors Can Predict the Progression of Parkinson’s Disease
16 Dec 2011 - Parkinson’s disease is marked by the abnormal accumulation of α-synuclein and the early loss of dopamine neurons in the substantia nigra region of the brain. A polymorphism in the promotor of α-synuclein gene known as NACP-Rep1 has been implicated as a risk factor for the disease. Now, researchers have found that different variants of NACP-Rep1 and its interaction with the microtubule-associa...
New Study First to Link Mitochondrial Dysfunction and alpha-Synuclein Multiplication in Human Fibroblasts
07 Oct 2011 - A new study in the Journal of Parkinson’s Disease shows for the first time the effects of α-Synuclein (α-syn) gene multiplication on mitochondrial function and susceptibility to oxidative stress in human tissue. Mitochondrial dysfunction has been frequently implicated in the neurodegenerative process that underlies Parkinson’s disease, but the basis for this has not been fully understood. ...
Ability to Ride a Bike Can Aid Differential Diagnosis of Parkinson’s Disease in Any Setting
07 Oct 2011 - In a new study published today in the Journal of Parkinson’s Disease, Japanese researchers report that the ability to ride a bike can differentiate between atypical parkinsonism and Parkinson’s disease, regardless of the environment or situations for bicycling. ...